Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CVS HEALTH CORPORATION

(CVS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Insider Sell: CVS Health

09/08/2021 | 11:24am EDT


© MT Newswires 2021
All news about CVS HEALTH CORPORATION
10/22Walmart, Walgreens U.S. stores roll out Moderna, J&J COVID-19 booster shots
RE
10/22CVS HEALTH : Pharmacies Start Offering Moderna COVID-19 Booster Shots
MT
10/22CVS HEALTH : Announces Availability of Moderna Booster to Eligible Populations
PR
10/21CVS HEALTH CORPORATION : Ex-dividend day for
FA
10/19REINVENTING HEALTH CARE : The Aetna Connected Plan with CVS Health™ is helping deliv..
PR
10/18CVS Health Names Joneigh S. Khaldun as Chief Health Equity Officer
CI
10/15CVS HEALTH : names Dr. Joneigh S. Khaldun as Vice President and Chief Health Equity Office..
PU
10/12VC DAILY : Is It All or Nothing for Founders?
DJ
10/06AMAZON COM : Bank of America raises U.S. minimum hourly wage to $21
RE
10/05CVS HEALTH : Keeps Quarterly Dividend Unchanged at $0.50 a Share, Payable Nov. 1 to Shareh..
MT
More news
Analyst Recommendations on CVS HEALTH CORPORATION
More recommendations
Financials (USD)
Sales 2021 284 B - -
Net income 2021 8 470 M - -
Net Debt 2021 48 981 M - -
P/E ratio 2021 13,7x
Yield 2021 2,28%
Capitalization 115 B 115 B -
EV / Sales 2021 0,58x
EV / Sales 2022 0,54x
Nbr of Employees 256 500
Free-Float 75,6%
Chart CVS HEALTH CORPORATION
Duration : Period :
CVS Health Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CVS HEALTH CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 27
Last Close Price 87,52 $
Average target price 97,05 $
Spread / Average Target 10,9%
EPS Revisions
Managers and Directors
Karen S. Lynch President, Chief Executive Officer & Director
Shawn M. Guertin Chief Financial Officer & Executive Vice President
David Wyatt Dorman Chairman
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
Sector and Competitors